Ligand enters financing deal with AvenCell Therapeutics for up to $47 million
Bitget2026/09/24 11:02- Ligand Pharmaceuticals entered a financing agreement with AvenCell Therapeutics to fund next-generation allogeneic CAR-T programs for up to $47 million.
- Commitment includes up to $41 million for a mid single-digit to low double-digit royalty on worldwide net sales across AvenCell’s pipeline.
- Funding will be paid in four tranches, with later payments tied to clinical milestones and specified financing conditions.
- Ligand also committed up to $6 million in a concomitant Series C financing.
- Proceeds target development of AVC-201 in a Phase 1b AML expansion study, with AVC-203 in Phase 1a for B-cell malignancies.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Swiss Franc remains near 16-month lows as rate hike odds lift US Dollar
Rapid rise in real interest rates, Goldman Sachs warns that 'systematic selling pressure' in US stocks is building at quarter-end
Goldman Sachs believes that the rapid rise in real interest rates has exerted more direct pressure on the US stock market, with rate-sensitive sectors such as small-cap and financial stocks being particularly affected. On the liquidity front, Goldman Sachs estimates that pension funds may sell around $3.3 billions in equities at the end of the month and quarter, and that CTAs may sell about $530 million worth of Russell 2000 index futures in the coming week. For the market, unless the issues of oil and interest rates are resolved, the AI narrative is "almost irrelevant."
USD/JPY falls below 157! The yen becomes the strongest G-10 currency, with the market betting on another rate hike by the central bank next month.
On Wednesday, the yen strengthened against the US dollar, with the USD/JPY rate falling below the 157 mark, as repeated warnings from the Japanese government regarding exchange rates and end-of-quarter capital flows provided support for the yen.
The scale of the compute power agreement between Anthropic and SpaceX has been revealed, reaching up to $84.5 billions, double the previously disclosed amount.
According to Anthropic’s IPO prospectus, the company has signed a computing power leasing agreement with SpaceX valued at $84.5 billion, far surpassing the previously disclosed $45 billion in SpaceX’s IPO documents. The agreement runs until 2029, with most terms cancellable within 90 days. At the same time, Anthropic’s total spending on AI infrastructure over the next decade is expected to be at least $518 billion.
Crypto prices
More
